Mon panier

IFN-alpha 2b

IFN-alpha 2b Informations sur la molécule

Nom anglaisInterferon alpha-2Nombre de médicaments commercialisés1
Nombre de médicaments cliniques10Alias de la cibleIFNA2B,IFNA2C,LeIF A,Interferon alpha-2,IFN-alpha-2,IFNA2,Interferon Alpha 2,Alpha-2a Interferon,Interferon Alpha 2b,Interferon Alpha A,Interferon Alpha 2a,Interferon Alpha-A,IFN-AlphaA,IFNA2A,INFA2,IFNA
Phase de R&D la plus avancéeApproved
Nom anglaisInterferon alpha-2
Alias de la cibleIFNA2B,IFNA2C,LeIF A,Interferon alpha-2,IFN-alpha-2,IFNA2,Interferon Alpha 2,Alpha-2a Interferon,Interferon Alpha 2b,Interferon Alpha A,Interferon Alpha 2a,Interferon Alpha-A,IFN-AlphaA,IFNA2A,INFA2,IFNA
Nombre de médicaments commercialisés1
Nombre de médicaments cliniques10
Phase de R&D la plus avancéeApproved

IFN-alpha 2b Liste de produits

  • Attribut

    Protein (2)

  • Bibliothèque de produits

    En ligne (2)

  • Espèces

    Human (2)

  • Étiquette

    Fc Tag (1)His Tag & Avi Tag (1)

  • Marqueur

    Unconjugated (1)Biotin-labeled (1)

Numéro de produitEspècesSystème d'expressionDescription du produitStructure protéiquePuretéCaractéristiquesPré-commande/Commande
IFB-H5253
Human
HEK293
Human IFN-alpha 2b Protein, Fc Tag (MALS verified)
Ajouter au panier
IFB-H82E3
Human
HEK293
Biotinylated Human IFN-alpha 2b Protein, His,Avitag™ (MALS verified)
Ajouter au panier
Quantité totale2
  • 1

IFN-alpha 2bContexte de la molécule

IFN-alpha is a cytokine that has an immunomodulatory function. It plays an important role not only in antiviral activity but also in several physiologic functions, such as activation of dendritic cells and accelerated expression of major histocompatibility complex I and II molecules that may cause increased antigen presentation. Variants of human leukocyte interferon alpha 2 (IFN-alpha 2a, alpha 2b, and alpha 2c) differ from each other by changes in their coding regions at nucleotide positions 137 and 170. IFN-alpha 2b (IFNα-2b) is an important cytokine and used for antiviral and anticancer treatment.

IFN-alpha 2bAlias de la molécule

IFN-alpha 2b,IFNA2B,IFN-alpha 2 (alpha 2b),interferon alpha 2b

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Autologous CD34+-enriched hematopoietic stem and progenitor cells (Genenta Science)Phase 2 ClinicalGenenta Science SrlCarcinoma, Renal Cell; Glioblastoma; Multiple Myeloma
Details
NG-641EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAPPhase 1 ClinicalAkamis Bio LtdNeoplasm Metastasis; Neoplasms, Glandular and Epithelial; Squamous Cell Carcinoma of Head and Neck
Details
recombinant human serum albumin-interferon-alpha-2a fusion protein (Qilu Pharmaceutical)Phase 1 ClinicalQilu Pharmaceutical Co LtdHepatitis B
Details
Q101-pegylated interferon alfa-2a (CSPC Zhongqi Pharmaceutical Technology)Phase 1 ClinicalCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co LtdHepatitis B, Chronic
Details
PEGylated interferon alpha-1b (Shanghai Institute of Biological Products)Phase 1 ClinicalShanghai Institute of Biological Products Co LtdHepatitis B; Neoplasms; Varicella Zoster Virus Infection
Details
SFR-1882SFR-1882Phase 1 ClinicalTianjin Sinobiotech LtdAnemia; Renal Insufficiency
Details
CX-801CX-801Phase 1 ClinicalCytomx Therapeutics IncCarcinoma, Renal Cell; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
ORB-011ORB-011Phase 1 ClinicalNeoplasms; Solid tumours
Details
interferon alfa-2b follow-on biologic (Amoytop)ClinicalXiamen Amoytop Biotech Co LtdCondylomata Acuminata; Hepatitis B; Hepatitis C; Leukemia, Hairy Cell; Lymphoma, Follicular; Melanoma; Sarcoma, Kaposi
Details
interferon-alpha2b (The University Health Network)ClinicalUniversity Health Network (Uhn)Coronavirus Disease 2019 (COVID-19)
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Nadofaragene firadenovecSCH-721015; FE-999326; SCH-209702/SCH-721015; SCH-721015/SCH-209702; TR-002ApprovedFkd Therapies, Schering-Plough Labo NvInstiladrin, AdstiladrinUnited StatesUrinary Bladder NeoplasmsFerring Pharmaceuticals A/S2022-12-16Adenocarcinoma; Carcinoma, Transitional Cell; Mesothelioma; Pancreatic Neoplasms; Solid tumours; Urinary Bladder Neoplasms
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments commercialisés
  • Informations sur les médicaments cliniques